Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal vs. Oral Estrogen on Androgens and Thyroid in Menopause
NCT00224094Phase 4Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- Jan 2002
- Primary completion
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ethinyl estradiol + desogestrel in menopause (2 arms), sponsored by Watson Pharmaceuticals. Primary endpoint: Free testosterone concentrations at 12 weeks. Started Jan 2002; status: completed.
02
Drugs
ethinyl estradiol + desogestrel
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00224094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224094.